The core activity of SWAN Isotopen AG is the production and distribution of radiopharmaceuticals for nuclear medicine, particularly for molecular diagnostics. This includes the development and production of short-lived radiopharmaceuticals as well as the transportation of radioactive materials. The company operates a state-of-the-art production facility on the campus of the Inselspital in Bern and works closely with the University of Bern and other research institutions.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
GMP-compliant manufacture and distribution of radiopharmaceuticals for molecular diagnostics; production on the campus of Inselspital Bern, focusing on nuclear medicine applications and oncology.
PET Tracers
PET tracers for nuclear medicine, including FDG Flu-SWAN, SWAN-PSMA-1007, FCH SWAN-Choline and FBB Neuraceq; ready-to-use radiodiagnostics for PET applications.
Preparation according to Formula magistralis
Manufacture of radiopharmaceuticals on medical prescription according to Formula magistralis, in particular with gallium-68 (Ga-68) and lutetium-177 (Lu-177).
Dangerous Goods Transport Class 7
Transport of radioactive materials and radiopharmaceutical as well as pharmaceutical consignments with an in-house equipped fleet; transports in Class 7 and for third parties.
Dangerous Goods Safety Adviser Class 7
External professional and legally compliant handling of transports of radioactive substances by a dangerous goods safety adviser, when no in-house qualified employee is available.